Managing Erectile Dysfunction in Hypertensive Patients

Journal of Clinical Hypertension

Volumn 13, Issue 6, 2011, Pages 450-454

  Handler, Joel ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; AMLODIPINE; ATENOLOL; CHLORTALIDONE; DOXAZOSIN; HYDROCHLOROTHIAZIDE; LISINOPRIL; LOSARTAN; NEBIVOLOL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CASE REPORT; DIZZINESS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERECTILE DYSFUNCTION; HEADACHE; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; SEXUAL INTERCOURSE; SYSTOLIC BLOOD PRESSURE; THROAT IRRITATION;

AMIDES; ANTIHYPERTENSIVE AGENTS; BENZOPYRANS; CHLORTHALIDONE; ETHANOLAMINES; FUMARATES; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; IMPOTENCE, VASCULOGENIC; LOSARTAN; MALE; MIDDLE AGED; RISK FACTORS;

EID: 79958263536     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2011.00465.x     Document Type: Article

References (43)

1. Spitzer RL, Kroenke K, Williams JBW, et al. Validation and utility of a self-report version of PRIME-MD. The PHQ primary care study. JAMA. 1999;282:1737-1744.
2. NIH Consensus Development Panel on Impotence. Impotence. JAMA. 1993;270:83-90.
3. Manolis A, Doumas M. Sexual dysfunction: the 'prima ballerina' of hypertension-related quality-of-life complications. J Hypertens. 2008;26:2074-2084.
4. Papatsoris AG, Korantzopoulis PG. Hypertension, antihypertensive therapy, and erectile dysfunction. Angiology. 2006;57:47-52.
5. Doumas M, Tsakiris A, Douma S, et al. Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects. J Androl. 2006;27:469-477.
6. Langford HG, Rockhold RW, Wassertheil-Smoller S, et al. Effect of weight loss on thiazide produced erectile problems in men. Trans Am Clin Climatol Assoc. 1990;101:190-194.
7. Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction. J Urol. 1999;161:5-11.
8. Francis ME, Kusek JW, Nyberg LM, et al. The contribution of common medical conditions and drug exposures to erectile dysfunction in adult males. J Urol. 2007;178:591-596.
9. Prisant LM. Chapter C155 Sexual dysfunction and hypertension. In: Izzo JL, Sica DA, Black HR, eds. American Heart Association Hypertension Primer. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:519-522.
10. Grimm RH, Grandits GA, Prineas RJ, et al. Long term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension. 1997;29:8-14.
11. Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of mild hypertension study final results. JAMA. 1993;270:713-724.
12. Hypertension Detection and Follow up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program 1. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA. 1979;242:2562-2571.
13. Curb JD, Borhani NO, Blaszkowski TP, et al. Long-term surveillance for adverse effects of antihypertensive drugs. JAMA. 1985;253:3263-3268.
14. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ. 1985;291:97-104.
15. Report of Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propanolol for the treatment of mild hypertension. Lancet. 1981;2:539-543.
16. Chang SW, Fine R, Siegel D, et al. The impact of diuretic therapy on reported sexual function. Arch Intern Med. 1991;151:2402-2408.
17. Prisant LM, Weir MR, Frishman WH, et al. Self reported sexual dysfunction in men and women treated with bisoprolol, hydrochlorothiazide, enalapril, amlodipine, placebo, or bisoprolol/hydrochlorothiazide. J Clin Hypertens. 1999;1:22-26.
18. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med. 1993;328:914-921.
19. Smith PJ, Talbert RL. Sexual dysfunction with antihypertensive and antipsychotic agents. Clin Pharm. 1986;5:373-384.
20. Wassertheil-Smoller S, Blaufox MD, Oberman A, et al. Effect of antihypertensives on sexual function and quality of life: the TAIM study. Ann Intern Med. 1991;114:613-620.
21. Lamina S, Okoye CG, Dagogo TT. Therapeutic effect of an interval exercise training program in the management of erectile dysfunction in hyptertensive patients. J Clin Hypertens. 2009;11:125-129.
22. Esposito K, Giugliano F, Palo CD, et al. Effect of lifestyle changes on erectile dysfunction in obese men. A randomized controlled trial. JAMA. 2004;291:2978-2984.
23. Bacon CG, Mittleman MA, Kawachi I, et al. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med. 2003;139:161-168.
24. Mikhailidis DP, Khan MA, Milionis HJ, et al. The treatment of hypertension in patients with erectile dysfunction. Curr Med Res Opin. 2000;16(suppl 1):S31-S36.
25. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2000;283:1967-1975.
26. Rosen RC, Cappelleri JC, Gendrano N. The international index of erectile dysfunction (IIEF): a state-of-the-science review. Int J Impot Res. 2002;14:226-244.
27. Fogari R, Preti P, Zoppi A, et al. Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women. Am J Hypertens. 2004;17:77-81.
28. Dusing R. Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Press. 2003;12(suppl 2):29-34.
29. Lindholm LH, Persson M, Alaupovic P, et al. Metabolic outcome during 1 year in newly detected hypertensives: results of the antihypertensive treatment and lipid profile in a north of Sweden efficacy evaluation (ALPINE study). J Hypertens. 2003;21:1563-1574.
30. Ferrario CM, Levy P. Sexual dysfunction in patients with hypertension: implications for therapy. J Clin Hypertens. 2002;4:424-432.
31. Doumas M, Douma S. The effect of antihypertensive drugs on erectile function: a proposed management algorithm. J Clin Hypertens. 2006;8:359-364.
32. Hackett G. Hypertensive medication and erectile dysfunction. Cardiovasc Ther. 2010;28:5-7.
33. Biswas PN, Wilton LV, Shakir SW. The safety of valsartan: results of a postmarketting surveillance study on 12, 881 patients in England. J Hum Hypertens. 2002;16:795-803.
34. Brixius K, Middeke M, Lichtenthal A, et al. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men. Clin Exp Pharmacol Physiol. 2007;34:327-331.
35. Doumas M, Tsakiris A, Douma S, et al. Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients. Asian J Androl. 2006;8:177-182.
36. Cordero A, Bertomeu-Martinez V, Mazon P, et al. Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents. Cardiovasc Ther. 2010;28:15-22.
37. Ko DT, Hebert PR, Coffey CS, et al. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 2002;288:351-357.
38. Barsky AJ, Saintfort R, Rogers MP, et al. Nonspecific medication side effects and the nocebo phenomenon. JAMA. 2002;287:622-627.
39. Myers MG. Patient information for prescription drugs - consequences of misinformation. Can J Clin Pharmacol. 1996;3:10-11.
40. Fung V, Sinclair F, Wang H, et al. Patients' perspectives on nonadherence to statin therapy: a focus-group study. Perm J. 2010;14:4-10.
41. Silvestri A, Galetta P, Cerquetani E, et al. Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Euro Heart J. 2003;24:1928-1932.
42. Venetikou MS, Lambou T, Gizani D. Hyperprolactinemia due to hypothalamic-pituitary disease or drug-induced in patients with erectile dysfunction. Andrologia. 2008;40:240-244.
43. Hyde Z, Flicker L, Hankey GJ, et al. Prevalence of sexual activity and associated factors in men aged 75 to 95 years. A cohort study. Ann Intern Med. 2010;153:693-702.